Cheung IY, Cheung NV, Modak S, Mauguen A, et al. Survival Impact of Anti-GD2 Antibody Response in a Phase II Ganglioside Vaccine Trial Among Patients With High-Risk Neuroblastoma With Prior Disease Progression. J Clin Oncol 2021;39:215-226.
PMID: 33326254